245 related articles for article (PubMed ID: 35577033)
1. Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids.
Amaral AU; Wajner M
Neurochem Int; 2022 Jul; 157():105360. PubMed ID: 35577033
[TBL] [Abstract][Full Text] [Related]
2. Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro.
Mescka CP; Wayhs CA; Guerreiro G; Manfredini V; Dutra-Filho CS; Vargas CR
Gene; 2014 Sep; 548(2):294-8. PubMed ID: 25046137
[TBL] [Abstract][Full Text] [Related]
3. Morphological alterations and induction of oxidative stress in glial cells caused by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.
Funchal C; Latini A; Jacques-Silva MC; Dos Santos AQ; Buzin L; Gottfried C; Wajner M; Pessoa-Pureur R
Neurochem Int; 2006 Dec; 49(7):640-50. PubMed ID: 16822590
[TBL] [Abstract][Full Text] [Related]
4. Acute effects of intracerebroventricular administration of α-ketoisocaproic acid in young rats on inflammatory parameters.
Rabelo F; Lemos IDS; Dal Toé CP; Casagrande DD; Freitas MLS; Quadra MR; Lima IR; Generoso JS; Michels M; Silveira PCL; Pizzol FD; Streck EL
Metab Brain Dis; 2023 Jun; 38(5):1573-1579. PubMed ID: 36897514
[TBL] [Abstract][Full Text] [Related]
5. Blood and tissue branched-chain amino and alpha-keto acid concentrations: effect of diet, starvation, and disease.
Hutson SM; Harper AE
Am J Clin Nutr; 1981 Feb; 34(2):173-83. PubMed ID: 7211722
[TBL] [Abstract][Full Text] [Related]
6. Effect of the branched-chain alpha-keto acids accumulating in maple syrup urine disease on S100B release from glial cells.
Funchal C; Tramontina F; Quincozes dos Santos A; Fraga de Souza D; Gonçalves CA; Pessoa-Pureur R; Wajner M
J Neurol Sci; 2007 Sep; 260(1-2):87-94. PubMed ID: 17499767
[TBL] [Abstract][Full Text] [Related]
7. Creatine and antioxidant treatment prevent the inhibition of creatine kinase activity and the morphological alterations of C6 glioma cells induced by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.
Funchal C; Schuck PF; Santos AQ; Jacques-Silva MC; Gottfried C; Pessoa-Pureur R; Wajner M
Cell Mol Neurobiol; 2006 Feb; 26(1):67-79. PubMed ID: 16633902
[TBL] [Abstract][Full Text] [Related]
8. Evidence that the branched-chain alpha-keto acids accumulating in maple syrup urine disease induce morphological alterations and death in cultured astrocytes from rat cerebral cortex.
Funchal C; Gottfried C; De Almeida LM; Wajner M; Pessoa-Pureur R
Glia; 2004 Nov; 48(3):230-40. PubMed ID: 15390119
[TBL] [Abstract][Full Text] [Related]
9. Apoptotic signaling pathways induced by acute administration of branched-chain amino acids in an animal model of maple syrup urine disease.
Vilela TC; Scaini G; Furlanetto CB; Pasquali MA; Santos JP; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Streck EL
Metab Brain Dis; 2017 Feb; 32(1):115-122. PubMed ID: 27510712
[TBL] [Abstract][Full Text] [Related]
10. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
[TBL] [Abstract][Full Text] [Related]
11. Treatment of maple syrup urine disease: Benefits, risks, and challenges of liver transplantation.
Deon M; Guerreiro G; Girardi J; Ribas G; Vargas CR
Int J Dev Neurosci; 2023 Oct; 83(6):489-504. PubMed ID: 37340513
[TBL] [Abstract][Full Text] [Related]
12. Branched-chain amino acids (BCAA) administration increases autophagy and the autophagic pathway in brain tissue of rats submitted to a Maple Syrup Urine Disease (MSUD) protocol.
Fermo KT; da Silva Lemos I; Farias HR; Rosso MP; Effting PS; Leipnitz G; Streck EL
Metab Brain Dis; 2023 Jan; 38(1):287-293. PubMed ID: 36305998
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease.
Sgaravatti AM; Rosa RB; Schuck PF; Ribeiro CA; Wannmacher CM; Wyse AT; Dutra-Filho CS; Wajner M
Biochim Biophys Acta; 2003 Nov; 1639(3):232-8. PubMed ID: 14636955
[TBL] [Abstract][Full Text] [Related]
14. alpha-keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defences in cerebral cortex from young rats.
Bridi R; Braun CA; Zorzi GK; Wannmacher CM; Wajner M; Lissi EG; Dutra-Filho CS
Metab Brain Dis; 2005 Jun; 20(2):155-67. PubMed ID: 15938133
[TBL] [Abstract][Full Text] [Related]
15. Maple syrup urine disease: clinical, EEG, and plasma amino acid correlations with a theoretical mechanism of acute neurotoxicity.
Korein J; Sansaricq C; Kalmijn M; Honig J; Lange B
Int J Neurosci; 1994 Nov; 79(1-2):21-45. PubMed ID: 7744549
[TBL] [Abstract][Full Text] [Related]
16. Administration of branched-chain amino acids alters epigenetic regulatory enzymes in an animal model of Maple Syrup Urine Disease.
Streck EL; Bussular FP; Wessler LB; Duarte MB; Rezende VL; Rodrigues MS; Torres CA; Lemos IS; Candiotto G; Gava FF; de Oliveira J; Valvassori SS
Metab Brain Dis; 2021 Feb; 36(2):247-254. PubMed ID: 33098071
[TBL] [Abstract][Full Text] [Related]
17. Renal clearance of branched-chain L-amino and 2-oxo acids in maple syrup urine disease.
Schadewaldt P; Hammen HW; Ott AC; Wendel U
J Inherit Metab Dis; 1999 Aug; 22(6):706-22. PubMed ID: 10472531
[TBL] [Abstract][Full Text] [Related]
18. Quantification of Branched-Chain Amino Acids in Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
Piri-Moghadam H; Miller A; Pronger D; Vicente F; Charrow J; Haymond S; Lin DC
Methods Mol Biol; 2022; 2546():65-81. PubMed ID: 36127579
[TBL] [Abstract][Full Text] [Related]
19. Metformin inhibits Branched Chain Amino Acid (BCAA) derived ketoacidosis and promotes metabolic homeostasis in MSUD.
S Sonnet D; N O'Leary M; A Gutierrez M; M Nguyen S; Mateen S; Hsu Y; P Mitchell K; J Lopez A; Vockley J; K Kennedy B; Ramanathan A
Sci Rep; 2016 Jul; 6():28775. PubMed ID: 27373929
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
